Myelofibrosis - PDFSEARCH.IO - Document Search Engine

Myelofibrosis
Results: 65

#	Item
11	NonChem Qualitative 1Q2015.xlsx Add to Reading List Source URL: www.aab-pts.org Language: English - Date: 2015-04-15 17:39:34 Lymphatic system Stem cells Myelofibrosis Hematology Myeloproliferative disease Splenomegaly Lymphocyte Bone marrow Platelet Medicine Biology Anatomy
12	Eur J Nucl Med Mol Imaging[removed]:166–178 DOI[removed]s00259[removed]REVIEW ARTICLE Radionuclide imaging of bone marrow disorders Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Stem cells Myeloid leukemia Hematopoiesis Lymphatic system Hematology Myelofibrosis Haematopoiesis Acute myeloid leukemia Aplastic anemia Medicine Biology Oncology
13	Effective Practices in MYELOFIBROSIS Programs Association of Community Add to Reading List Source URL: www.accc-cancer.org Language: English - Date: 2015-03-27 09:37:40 Thrombocytosis Oncology Cancer organizations Medicine Myelofibrosis Essential thrombocytosis
14	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Pharmaceutical Benefits Scheme Pharmacology Myelofibrosis International Prognostic Scoring System IPSS Clinical trial Medicine Health Ruxolitinib
15	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer representa Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Pharmaceutical Benefits Scheme Pharmacology Myelofibrosis International Prognostic Scoring System IPSS Clinical trial Medicine Health Ruxolitinib
16	ruxolitinib (as phosphate), 5mg, 15mg, & 20mg tablets (Jakavi®) SMC No[removed]Novartis Pharmaceuticals UK Ltd. 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above produc Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Janus kinase inhibitor Placebo Thrombocytosis Polycythemia vera Splenomegaly Leukemia Medicine Ruxolitinib Myelofibrosis
17	Table 13.1 Classification of acute myeloid leukaemia (AML) according to the WHO classification[removed]modified). Acute myeloid leukaemia with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 Add to Reading List Source URL: www.essentialhaematology6.com Language: English - Date: 2011-02-25 06:19:27 Acute myeloid leukemia Acute promyelocytic leukemia RUNX1 Myelodysplastic syndrome CEBPA Leukemia Acute panmyelosis with myelofibrosis Auer rod Myeloid sarcoma Myeloid leukemia Medicine Acute leukemia
18	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Pharmaceutical Benefits Scheme Pharmacology Myelofibrosis International Prognostic Scoring System IPSS Clinical trial Medicine Health Ruxolitinib
19	Title: Molecular testing for myeloproliferative disease Part A – Polycythaemia vera (PV), essential thrombocythaemia (ET) and primary myelofibrosis (PMF) Part B – Systemic mast cell disease (SMCD), hypereosinophilic Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-01-28 18:33:56
20	Medical Services Advisory Committee Public Summary Document Application No. 1125 – Molecular testing for myeloproliferative disease Sponsor: Pathology Services Table Committee, Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-01-28 18:33:52 Bone marrow examination Polycythemia vera Myelofibrosis Biopsy Thrombocytosis Polycythemia Pathology Medicine Hematopathology Myeloproliferative disease

UPDATE